BioSig Technologies, Inc. announces intention to offer shares of common stock through public offering.
Offering proceeds to be used for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company acting as joint book-running managers.
Offering Details
Shares of common stock to be offered for purchase, with the use of proceeds specified.
Book-Running Managers
Clear Street and Needham & Company are facilitating the offering process.
Registration Statement
Offering made under a shelf registration statement on Form S-3 filed with the SEC.
Prospectus Information
Interested parties advised to review the prospectus supplement and accompanying base prospectus before investing.
- BioSig Technologies aims to bolster its financial position through the public offering.
- The merger with Streamex Exchange Corporation enhances the company's market presence.
- The strategic allocation of offering proceeds may further solidify BioSig's investment strategy.
The proposed public offering presents a strategic opportunity for BioSig Technologies to strengthen its financial position and pursue its investment objectives.